Please ensure Javascript is enabled for purposes of website accessibility

Congress Cares About Your Ears

By Adrian Rush – Updated Oct 4, 2017 at 9:29AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

A vote is expected today on a bill that would quiet down those noisy TV ads.

Even as America's warring factions take sides while our lawmakers in Washington debate the contentious issues of the day, there's one bill before Congress that couch potatoes can apparently all get behind: a proposal to tone down those noisy TV commercials.

According to the AP, a House vote is expected today on a bill that would prevent ads from broadcasting at a notably louder volume than the program with which they air. That's right: No longer would your eardrums bleed when that ShamWow guy comes on and starts screaming at you at a volume louder than the explosion that happened during your favorite crime procedural before the break.

Clearly, this issue is of great national concern to the American people. "In my 17 years in the House of Representatives, I've never carried a bill which has been received with so much enthusiasm," said Rep. Anna Eshoo, D-Calif., sponsor of the Commercial Advertisement Loudness Mitigation Act, otherwise known as the CALM Act. Leave it to Congress to come up with an acronym for everything, and to the American people for knowing what issues of the day are really important.

Health care? Pfft. We just don't want Pfizer (NYSE:PFE) blaring the "Viva Viagra" song at us, or Verizon (NYSE:VZ) constantly reminding us about AT&T's (NYSE:T) 3G deficiencies.

What's your opinion, Fools? Is this a bill of crucial national importance? Or are you content just to flip past the ads with your TiVo (NASDAQ:TIVO) device or -- gasp! -- hit the mute button? Sound off in the comments box below.

Fool online editor Adrian Rush doesn't watch much TV, outside of sports. He has no position in any of the stocks mentioned here. Pfizer is an Inside Value recommendation. The Fool's disclosure policy attended Billy Mays' memorial service.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Verizon Communications Stock Quote
Verizon Communications
VZ
$37.00 (1.18%) $0.43
AT&T Stock Quote
AT&T
T
$16.74 (7.72%) $1.20
Pfizer Stock Quote
Pfizer
PFE
$42.91 (-0.46%) $0.20
TiVo Stock Quote
TiVo
TIVO

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
340%
 
S&P 500 Returns
106%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 10/21/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.